episode-header-image

Jul 30

25m 16s

Mansoor Farahani, Wafaa El-Sadr, and Wil...

The Lancet Group

About this episode

Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country.

Read the full article:

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Up next

Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV

In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results.Read the full article:https://www.thelancet.com/journals/lanhiv/ ... Show More

Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese ... Show More

Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality

Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss thei ... Show More

Recommended Episodes

Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma

Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk pa ... Show More

Episode 008: Metastatic Cancer of “Origin TBD”

Not to be confused with “carcinoma of unknown primary,” in this episode of metastatic disease of “origin TBD”, we discuss the workup of a mass noted incidentally on imaging. This is a very high yield topic often faced on solid oncology consults! Major Points Covered:Mass found in ... Show More

Professor Joël Guigay on clinical trials of older patients with head and neck cancer

Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.Read the full articles:https://www.thelancet.com/ ... Show More

Olympian Sir Chris Hoy wants more tests for prostate cancer - should it happen?

Olympic cyclist Sir Chris Hoy is calling for more prostate cancer testing after he was diagnosed with terminal cancer. Prostate cancer can often present without symptoms, and for people like Sir Chris, this can mean it isn't diagnosed until it has spread and become incurable. Unl ... Show More

From Breast Cancer Survivor to Advocate: Heather Salazar and Pink Ribbon Good

In this emotional episode of SHE MD, Dr. Thais Aliabadi and Mary Alice Haney host Heather Salazar, a breast cancer survivor and founder of Pink Ribbon Good. Heather shares her personal journey and the life-changing encounter that led to the establishment of Pink Ribbon Good. The ... Show More

Supplemental Breast Cancer Screening: Unmasking the Truth

Supplemental breast cancer screening is a very timely topic that every radiologist should know about. In this episode, based on my Radiology Review Insider article of the same name available at theradiologyreview.com, I provide an overview of the current supplemental screening la ... Show More

Listen to millions of songs and podcasts on Anghami